IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v4y2020i4d10.1007_s41669-020-00201-2.html
   My bibliography  Save this article

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

Author

Listed:
  • Fernando de Andrés-Nogales

    (Pharmacoeconomics & Outcomes Research Iberia (PORIB))

  • Miguel Ángel Casado

    (Pharmacoeconomics & Outcomes Research Iberia (PORIB))

  • José Luis Trillo

    (Departamento de Salud Clínico Malvarrosa)

  • José María Ruiz-Moreno

    (Universidad Castilla La Mancha, Albacete, Spain; Vissum Corporación, Spain; Hospital Universitario Puerta de Hierro Majadahonda
    RETICS-OFTARED, Instituto de Salud Carlos III)

  • José Manuel Martínez-Sesmero

    (Hospital Clínico San Carlos)

  • Gemma Peralta

    (Fundació Rossend Carrasco i Formiguera, MentBarcelona)

  • José Luis Poveda

    (Hospital Universitari i Politècnic La Fe)

  • Pere Ortiz

    (Consorci MAR Parc de Salut de Barcelona)

  • Emilio Ignacio

    (Universidad de Cádiz)

  • Javier Zarranz-Ventura

    (RETICS-OFTARED, Instituto de Salud Carlos III
    Instituto Clinic de Oftalmología, Hospital Clinic)

  • Patricia Udaondo

    (Hospital Universitari i Politècnic La Fe)

  • Carlos Mur

    (Hospital Universitario de Fuenlabrada)

  • Eloísa Álvarez

    (Hospital Clínico San Carlos)

  • Enrique Cervera

    (Hospital General Universitario de Valencia)

  • Mercedes Martínez

    (Ministerio de Sanidad, Consumo y Bienestar Social)

  • Iñaki Llorente

    (Hospital Universitario Nuestra Señora de la Candelaria)

  • Jacinto Zulueta

    (Asociación Mácula Retina)

  • Mariano Rodríguez-Maqueda

    (Hospital Universitario Virgen del Rocío)

  • Alfredo García-Layana

    (RETICS-OFTARED, Instituto de Salud Carlos III
    Clínica Universitaria de Navarra)

  • José Martínez-Olmos

    (Senado de España)

Abstract

Background The clinical and economic management of retinal diseases has become more complex following the introduction of new intravitreal treatments. Multicriteria decision analysis (MCDA) offers the potential to overcome the challenges associated with traditional decision-making tools. Objectives A MCDA to determine the most relevant criteria to decision-making in the management of diabetic macular edema (DME) based on the perspectives of multiple stakeholders in Spain was developed. This MCDA was termed the MULTIDEX-EMD study. Methods Nineteen stakeholders (7 physicians, 4 pharmacists, 5 health authorities and health management experts, 1 psychologist, and 2 patient representatives) participated in this three-phase project. In phase A, an advisory board defined all of the criteria that could influence DME treatment decision-making. These criteria were then screened using a discrete choice experiment (DCE) (phase B). Next, a multinomial logit model was fitted by applying the backward elimination algorithm (relevant criteria: p value

Suggested Citation

  • Fernando de Andrés-Nogales & Miguel Ángel Casado & José Luis Trillo & José María Ruiz-Moreno & José Manuel Martínez-Sesmero & Gemma Peralta & José Luis Poveda & Pere Ortiz & Emilio Ignacio & Javier Za, 2020. "A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study," PharmacoEconomics - Open, Springer, vol. 4(4), pages 615-624, December.
    • Handle: RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00201-2
    DOI: 10.1007/s41669-020-00201-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-020-00201-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-020-00201-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Blog mentions

    As found by EconAcademics.org, the blog aggregator for Economics research:
    1. Chris Sampson’s journal round-up for 21st December 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-12-21 12:00:05

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00201-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.